cancer immunotherapy

Genomics-Guided Off-Label Treatment: Prospective Evaluation

by

The “Wild West” era of off-label cancer treatment—where clinicians prescribe non-approved drugs based on scientific intuition and hope—is facing a necessary reckoning. For years, patients with exhausted treatment options have navigated a precarious landscape of high-cost, high-toxicity therapies with little to no systematic oversight. However, the long-term results of the Drug Rediscovery Protocol (DRUP) provide … Read more

CAR-T Cell Engineering: In Vivo Cancer Therapy

by

Revolutionary In Vivo CAR-T Therapy Shows Promise for Multiple Myeloma Patients In a significant leap forward for cancer treatment, early clinical data reveals that a novel in vivo CAR-T cell therapy is demonstrating encouraging results in patients battling multiple myeloma. This innovative approach, which engineers immune cells directly within the patient’s body, bypasses the complex … Read more

Pembrolizumab & Olaparib: Pancreatic Cancer Trial Results

by

Promising New Treatment Approach for Metastatic Pancreatic Cancer Identified In a significant development for patients battling advanced pancreatic cancer, early results from the phase 2 POLAR trial suggest a novel, biomarker-driven treatment strategy is yielding encouraging responses. The approach focuses on identifying patients with metastatic pancreatic cancer who exhibit homologous repair deficiency and possess immune … Read more

Cancer & Microbiome: Boosting Immunotherapy Success

by

Fecal Microbiota Transplantation Shows Promise in Boosting Cancer Immunotherapy In a significant advancement for cancer treatment, three independent clinical trials have demonstrated that fecal microbiota transplantation (FMT) can substantially improve the effectiveness of immunotherapy in patients with advanced solid tumors. The findings, representing a potential paradigm shift in how we approach cancer care, suggest that … Read more

Melanoma: 5-Year Survival with Ipi & Nivo Therapy

by

Melanoma Breakthrough: Five-Year Data Shows High Survival Rates with Novel Immunotherapy Approach Groundbreaking five-year follow-up data reveals remarkably positive outcomes for patients with high-risk stage III melanoma treated with a combination of immunotherapy drugs, followed by surgery and additional therapy tailored to their response. The findings, stemming from the PRADO extension cohort of the OpACIN-neo … Read more

Pancreatic Cancer: T-Cell Therapy – Phase 1/2 Trial

by

Promising New T Cell Therapy Shows Benefit in Pancreatic Cancer Trial In a significant development for patients battling pancreatic ductal adenocarcinoma, early results from the TACTOPS trial demonstrate the feasibility and safety of a novel autologous T cell therapy. The treatment, designed to target specific cancer-associated antigens, has yielded encouraging clinical responses and evidence of … Read more

Immune System Rejuvenation: New MIT Study Findings

by

mRNA Revolution: Can We Reset the Immune System to Fight Aging and Disease? Nearly 90% of deaths in the United States are attributable to chronic diseases, many of which are linked to age-related immune decline. But what if we could *reset* the immune system, restoring its youthful vigor and dramatically reducing our susceptibility to illness? … Read more

© 2026 Archyworldys. All rights reserved.

For contact, advertising, copyright, issues email: [email protected]